Predictors of chemoradiotherapy versus single modality therapy and overall survival among patients with unresectable, stage III non-small cell lung cancer | PLOS ONE
Overall survival curves of NSCLC cancer patients according to the TNM... | Download Scientific Diagram
Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands | Scientific Reports
Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC - Journal of Thoracic Oncology
5-year overall survival almost doubled with pembrolizumab for metastatic NSCLC patients with a PD-L1 TPS ≥ 50% and without EGFR/ALK alterations - BJMO
Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis | PLOS ONE
Overall survival from stage III NSCLC diagnosis by stage-based group.... | Download Scientific Diagram
Kaplan-Meier curve illustrating overall survival of all nsclc patients.... | Download Scientific Diagram
Overall survival by clinical stage according to the seventh edition (A)... | Download Scientific Diagram
Overall survival after surgical intervention for non-small cell lung... | Download Scientific Diagram
Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis | Radiation Oncology | Full Text
Incidence and survival of non-small cell lung cancer in Shanghai: a population-based cohort study | BMJ Open
Effect of targeted therapy and immunotherapy on advanced nonsmall‐cell lung cancer outcomes in the real world - Shokoohi - 2022 - Cancer Medicine - Wiley Online Library
IMFINZI® (durvalumab) Efficacy & Clinical Trials for NSCLC
Adjuvant chemotherapy improves overall survival in patients with stage IB non-small cell lung cancer
REVEL Trial Overall Survival for | CYRAMZA® (ramucirumab)
Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative | BMC Pulmonary Medicine | Full
Overall survival (OS) of all patients with stage IV non-small cell lung... | Download Scientific Diagram
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC | NEJM
Survival of patients with advanced NSCLC. a Overall survival of all... | Download Scientific Diagram
Cancers | Free Full-Text | Real World Outcomes versus Clinical Trial Results of Durvalumab Maintenance in Veterans with Stage III Non-Small Cell Lung Cancer
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health
Survival of patients with advanced NSCLC. a Overall survival of all... | Download Scientific Diagram
Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB/IV non-small cell lung cancer in China (2015–2017): A multicentre prospective study - The Lancet Regional Health – Western
The current treatment landscape in the UK for stage III NSCLC | British Journal of Cancer
